News
The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
6h
inews.co.uk on MSN1.5m Britons a month pay for weight-loss jabs – and pharmacies ‘ready’ to step upHigh-street pharmacies are ready to provide the jabs on the NHS and boost take-up for all, says senior pharmacist ...
TikTok creator Janelle Rohner revealed she is taking a GLP-1 medication for weight loss — despite selling $200 courses to ...
The rise in GLP-1 use among young women raises concerns about contraceptive efficacy and potential pregnancy risks. Learn ...
The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...
The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...
More dermatology patients are taking the popular drugs, but little is known about the biology of “Ozempic face” or how best ...
More than a billion people now have obesity worldwide, according to the WHO, and around 70% of them live in low and ...
Get your weekly dose of the top news that matters in our newsletter.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results